Voyager Therapeutics (VYGR)
(Real Time Quote from BATS)
$8.57 USD
-0.23 (-2.61%)
Updated Jun 14, 2024 10:12 AM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Brokerage Reports
Voyager Therapeutics, Inc. [VYGR]
Reports for Purchase
Showing records 121 - 140 ( 145 total )
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Positive Cohort 3 Data for Parkinson''s Study; Pivotal Study to Start Year End.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences: Upcoming Events for the Week of July 3
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Q1 Financials; Cohort Three Data Ahead; Ph 3 Study On Track; Reiterate OUTPERFORM and $36 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of May 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences: Upcoming Events for the Week of April 24
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences Upcoming Events for the Week of April 10.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Q4 Financials; On Track for Pivotal Study Initiation in Q4:17; Reiterate OUTPERFORM and $36 PT
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Coverage Data for Cohort 3 Reported; Topline Data on Track for Mid:17; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Large Improvements in Motor Function and Levodopa Response Validate VY-AADC01 Strategy in Advanced Parkinson''s Disease Patients; Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Q3 Financials; VY-AADC01 Topline Readout for Two Cohorts in December, Additional Protocol Optimizations to Inform Pivotal Study
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of Nov 7
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
HEALTHCARE - 2016 PacGrow Healthcare Conference Day 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Biotechnology/Biopharmaceuticals - 2016 PacGrow Healthcare Conference Day 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Q2 Results; VY-AADC01 Efficacy Data Ahead Could Provide Inflection Point, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
Coverage Data for Remaining Patients in Cohort 2 Above Threshold Likely Necessary for Clinical Efficacy, Reiterate OUTPERFORM
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences: Upcoming Events for the Week of June 20
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Voyager Therapeutics, Inc.
Industry: Medical - Generic Drugs
The Week Ahead in Life Sciences: Upcoming Events for the Week of June 13
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D